Navigation Links
Romantic partner may play role in reducing vulvovaginal pain
Date:9/9/2010

This release is available in French.

Montreal, September 9th, 2010 An investigation published in The Journal of Sexual Medicine has found that male partners who express greater support, attention and sympathy to women's chronic vulvovaginal pain may trigger more pain, but also increase sexual satisfaction in female partners.

Women who took part in the study, conducted by the University of Montreal and University of Montreal Hospital Research Centre, suffer from a condition called provoked vestibulodynia (PVD). A condition that affects 12 percent of premenopausal women, PVD can impair sexual functioning as well as diminish sexual desire, arousal, sexual satisfaction, orgasmic capacity and frequency of intercourse.

"An overly concerned partner may lead a woman to avoid sexual intercourse or exacerbate her pain by increasing her anxiety, hyper-vigilance and negative thoughts about the pain, which can in turn increase her pain during intercourse," says lead author, Dr. Natalie O. Rosen, a University of Montreal post-doctoral fellow in psychology. "If a man avoids sexual intercourse with a partner with PVD, then he may also reinforce her negative pain appraisals and that can lead to increased pain during intercourse."

At the same time, the researchers found that a more concerned attitude in partners was linked to greater sexual satisfaction in women with PVD. "It's likely that women interpret the attention from their partner as a greater sensitivity and understanding of her pain during sexual activity and that results in greater sexual satisfaction," says Rosen.

For couples affected by PVD, the key to decreasing pain and bolstering sexual satisfaction may be to shift the focus away from vaginal intercourse without avoiding sexual activity altogether. "Couples can focus on pleasurable sexual activities other than penetration, or on the emotional benefits of sexual activity such as intimacy and closeness," says Rosen.

As part of the study, 191 heterosexual couples affected by PVD completed questionnaires about the condition. Following their participation, couples received a 30-minute telephone psychological consultation about PVD.

"This study furthers our understanding of the importance of how couples communicate about PVD in predicting pain and sexual satisfaction in women," says Sophie Bergeron, a University of Montreal psychology professor. "The more the partner is overly concerned, from the perspective of the woman and her partner, the more her pain intensity may increase during intercourse. Results of our study can help in the development of targeted psychological interventions to assist couples in coping with PVD."


'/>"/>

Contact: Julie Gazaille
j.cordeau-gazaille@umontreal.ca
514-343-6796
University of Montreal
Source:Eurekalert

Related medicine news :

1. Study points out risks of nonromantic sexual relationships
2. Its the little things: Everyday gratitude as a booster shot for romantic relationships
3. Study links romantic rejection with reward and addiction centers in the brain
4. Sex between adolescents in romantic relationships is often harmless to their academics
5. CustomerCentric Selling and Kadient Announce Joint Event in Boston to Launch Strategic Partnership for Sales Enablement and Improvement
6. Diet-to-Go Welcomes 2 Key Philadelphia Fitness Centers as Partners-in-Health
7. Eastern Washington Jiffy Lube Service Centers Embark on Year Three of Successful Maintenance Partners For Life Campaign
8. Montana Jiffy Lube Service Centers Embark on Year Three of Successful Maintenance Partners For Life Campaign
9. Central Coast Jiffy Lube Service Centers Embark on Year Three of Successful Maintenance Partners For Life Campaign
10. Connecture, Inc. Announces Partnership with MedicareCRM
11. Maximized Living Named as Exclusive Chiropractic Partner of USA Weightlifting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/21/2017)... Palm Beach, FL (PRWEB) , ... April 21, 2017 , ... The staff at Palm ... , will be taking part in the 2017 London Marathon. Set to take place on ... of charitable organizations. This year, Dr. Schwartz will run as part of team EMPOWER, raising ...
(Date:4/21/2017)... ... April 21, 2017 , ... Evoke Therapy Programs , ... kicked off its 4th annual Forum for Innovative Treatment Solutions (FITS), which runs ... Therapy for Mental Health and Addiction.” , FITS’ 2017 keynote presenters will ...
(Date:4/21/2017)... ... April 21, 2017 , ... Dudnyk has announced the launch of its new ... the full potential of specialty and orphan brands can only be achieved when the ... “The Unifying Effect is at the heart of a true partnership between our agency ...
(Date:4/21/2017)... ... 2017 , ... The VIA Agency , a full-service ... Theravent, Inc. , the makers of a revolutionary new device clinically proven to ... working to expand distribution in anticipation of a national launch. VIA will be ...
(Date:4/21/2017)... ... April 21, 2017 , ... ... campaign, AWARE: A Week of Addiction and Recovery Education, from April 24 to ... and preventing substance use disorders. , The mission of AWARE is to ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)...  Cogentix Medical, Inc. (NASDAQ: CGNT), a global ... Uro/Gyn and Gynecology markets with innovative and proprietary ... the Company as Senior Vice President, Marketing & ... Keswani will report directly to Darin Hammers ... is delighted that Ash has joined the Cogentix ...
(Date:4/20/2017)... Mass. , April 20, 2017  RXi ... developing innovative therapeutics that address significant unmet medical ... data from the Company,s consumer product development program, ... at the Society for Investigative Dermatology (SID) 76 ... to advance and promote the sciences relevant to ...
(Date:4/20/2017)... -- AbbVie (NYSE: ABBV), a global biopharmaceutical company, today ... C virus (HCV) infected patients with genotype 1, ... (Child-Pugh A) achieved sustained virologic response at 12 ... pan-genotypic regimen of glecaprevir/pibrentasvir (G/P). These high SVR ... of G/P treatment without ribavirin. Patients with specific ...
Breaking Medicine Technology: